D-1823-2015 Class I Terminated
FDA drug recall D-1823-2015 was initiated by Pharmedium Services, LLC on Jan 28, 2015 and is designated Class I. Reason for recall: Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human… The recall status is terminated (terminated Jan 27, 2017). Affected quantity: 20 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- Sep 30, 2015
- Initiation Date
- Jan 28, 2015
- Termination Date
- Jan 27, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 20 bags
Product Description
Bupivacaine HCl 0.0625%, 250 mL total volume in a 250 mL LifeCare Bag in Sodium chloride 0.9%, Epidural Use Only, Rx Only, PharMEDium Services, LLC, 6100 Global Drive, Memphis, TN 36141, NDC# 61553-197-50
Reason for Recall
Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).
Distribution Pattern
Nationwide
Code Information
Lot #: 143140080M, Exp 02/09/15; 143210133M, Exp 02/16/15; 143490031M, Exp 03/16/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1823-2015
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026